Cargando…

Upregulation of HSF1 in estrogen receptor positive breast cancer

Heat shock transcription factor 1 (HSF1), a key regulator of the heat-shock response, is deregulated in many cancers. HSF1 can mediate cancer cell survival and metastasis. High levels of HSF1 have been associated with poor prognosis in breast cancer. The nature of HSF1 upregulation needs to be valid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gökmen-Polar, Yesim, Badve, Sunil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356658/ https://www.ncbi.nlm.nih.gov/pubmed/27713164 http://dx.doi.org/10.18632/oncotarget.12438

Ejemplares similares

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2018)

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues
por: Chen, Yi, et al.
Publicado: (2019)

Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2014)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer
por: Buechler, Steven A, et al.
Publicado: (2019)

Thymic Carcinomas and Second Malignancies: A Single-Center Review
por: Badve, Sunil S., et al.
Publicado: (2021)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Single cell heterogeneity in ductal carcinoma in situ of breast
por: Gerdes, Michael J, et al.
Publicado: (2017)

Spatially variant immune infiltration scoring in human cancer tissues
por: Allam, Mayar, et al.
Publicado: (2022)

ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing
por: Buechler, Steven A., et al.
Publicado: (2020)

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
por: Ghose, Soumya, et al.
Publicado: (2023)

Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells
por: Vydra, Natalia, et al.
Publicado: (2021)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Estrogen-Mediated Upregulation of Noxa Is Associated with Cell Cycle Progression in Estrogen Receptor-Positive Breast Cancer Cells
por: Liu, Wensheng, et al.
Publicado: (2011)

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021)

Modulating HSF1 levels impacts expression of the estrogen receptor α and antiestrogen response
por: Silveira, Maruhen AD, et al.
Publicado: (2021)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Molecular Analysis of Thymoma
por: Badve, Sunil, et al.
Publicado: (2012)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers
por: Williams, Michelle M., et al.
Publicado: (2019)

Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells
por: Kavarthapu, Raghuveer, et al.
Publicado: (2017)

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer
por: Shi, Liang, et al.
Publicado: (2015)

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016)

Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth
por: Carpenter, Richard L., et al.
Publicado: (2017)

Blockade of Estrogen Action Upregulates Estrogen Receptor-α mRNA in the Fetal Brain
por: Schaub, Christine E., et al.
Publicado: (2009)

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
por: Simigdala, Nikiana, et al.
Publicado: (2016)

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
por: Turk, Casey M, et al.
Publicado: (2012)

Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
por: McDermott, Martina S.J., et al.
Publicado: (2017)

Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
por: Chiu, Jen-Hwey, et al.
Publicado: (2017)

Quantitative Comparison of HSF1 Activators
por: Steurer, Christoph, et al.
Publicado: (2022)

Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines
por: Yndestad, Synnøve, et al.
Publicado: (2017)

A Gene Signature to Determine Metastatic Behavior in Thymomas
por: Gökmen-Polar, Yesim, et al.
Publicado: (2013)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

Estrogen receptor positive breast cancers and their association with environmental factors
por: St-Hilaire, Sophie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_or9cbouvje8lf6cltpneah1phs